Skip to main content

Table 2 Maternal exposure to medication, supplementation and illnesses during the pregestation and 1st trimester period

From: COVID-19 related risk factors and their association with non-syndromic orofacial clefts in five Arab countries: a case-control study

Variables

NSOFC (%)

Control (%)

P value

Maternal exposure to medication, supplementation and illnesses

Suplementation 3-months pregestation

Yes

68 (17.6)

124 (16.6)

0.651

No

318 (82.4)

625 (83.4)

Supplementations 1st trimester

Yes

313 (81.1)

616 (82.2)

0.632

No

73 (18.9)

133 (17.8)

Medications 3-months pregestation

Yes

90 (23.3)

113 (15.1)

< 0.001

No

296 (76.7)

636 (84.9)

Medications 1st trimester

Yes

41 (10.6)

72 (9.6)

0.591

No

345 (89.4)

677 (90.4)

Illness 3-months pregestation

Yes

96 (24.9)

166 (22.2)

0.304

No

290 (75.1)

583 (77.8)

Illness 1st trimester

Yes

95 (24.9)

163 (21.8)

0.230

No

286 (75.1)

586 (78.2)

Parental nicotine exposure

Mother smoking during pregestation

Yes

13 (3.4)

11 (1.5)

0.072

No

373 (96.6)

738 (98.5)

Father smoking during pregestation

Yes

167 (43.3)

273 (36.4)

0.026*

No

219 (56.7)

476 (63.6)

Mother smoking during 1st trimester

Yes

8 (2.1)

5 (0.7)

0.039*,b

No

378 (97.9)

744 (99.3)

Father smoking 1st trimester

Yes

148 (38.3)

253 (33.8)

0.128

No

238 (61.7)

496 (66.2)

Family factor

Family history of birth defects

Yes

132 (34.2)

35 (4.7)

< 0.001*

No

254 (65.8)

714 (95.3)

Consanguinity

Yes

173 (44.8)

270 (36.0)

0.005*

No

213 (55.2)

479 (64.0)

  1. *The Chi-square statistic is significant at the 0.05 level
  2. b Fissure exact test for cells with frequency 5 or less